These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26280156)

  • 21. Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index.
    Borghi A; Flacco ME; Zedde P; Toni G; Schettini N; Corazza M
    Dermatology; 2023; 239(1):81-90. PubMed ID: 36382657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial.
    Terras S; Gambichler T; Moritz RK; Stücker M; Kreuter A
    JAMA Dermatol; 2014 Jun; 150(6):621-7. PubMed ID: 24696010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children.
    Casey GA; Cooper SM; Powell JJ
    Clin Exp Dermatol; 2015 Apr; 40(3):289-92. PubMed ID: 25477189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.
    Lee A; Bradford J; Fischer G
    JAMA Dermatol; 2015 Oct; 151(10):1061-7. PubMed ID: 26070005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
    Unal M
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Searching for a "Window of Opportunity" in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment.
    Borghi A; Flacco ME; Schettini N; Toni G; Corazza M
    Dermatology; 2024; 240(2):195-204. PubMed ID: 38163426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
    Borghi A; Virgili A; Minghetti S; Toni G; Corazza M
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):96-101. PubMed ID: 28796915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study.
    Zaino ML; Pixley JN; Subramanian VM; Sirdeshmukh D; Feldman SR; Pichardo RO
    J Dermatolog Treat; 2024 Dec; 35(1):2285725. PubMed ID: 38240095
    [No Abstract]   [Full Text] [Related]  

  • 29. Measuring perceived benefit and disease-related burden in patients affected with vulvar lichen sclerosus after a standard topical corticosteroid treatment. Results from a cohort study using Pictorial Representation of Illness and Self-measure and Dermatology Life Quality Index.
    Borghi A; Odorici G; Scuderi V; Valpiani G; Morotti C; Corazza M
    Dermatol Ther; 2020 Nov; 33(6):e14334. PubMed ID: 32974986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment.
    Virgili A; Lauriola MM; Mantovani L; Corazza M
    Acta Derm Venereol; 2007; 87(1):69-72. PubMed ID: 17225019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
    Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
    Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does compliance to topical corticosteroid therapy reduce the risk of development of permanent vulvar structural abnormalities in pediatric vulvar lichen sclerosus? A retrospective cohort study.
    Kherlopian A; Fischer G
    Pediatr Dermatol; 2022 Jan; 39(1):22-30. PubMed ID: 34738263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact Allergy to Topical Mometasone Furoate Confirmed by Rechallenge and Patch Test.
    Tatu AL; Ionescu MA; Nwabudike LC
    Am J Ther; 2018; 25(4):e497-e498. PubMed ID: 28328785
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review.
    Mazzilli S; Diluvio L; Di Prete M; Rossi P; Orlandi A; Bianchi L; Campione E
    J Int Med Res; 2018 Sep; 46(9):3724-3728. PubMed ID: 30058419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Topical treatment of vulvar lichen sclerosus with calcineurin inhibitors].
    Maassen MS; van Doorn HC
    Ned Tijdschr Geneeskd; 2012; 156(36):A3908. PubMed ID: 22951124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.
    Spada F; Barnes TM; Greive KA
    Australas J Dermatol; 2018 Aug; 59(3):e168-e174. PubMed ID: 29411351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: a randomized controlled trial.
    Helgesen AL; Warloe T; Pripp AH; Kirschner R; Peng Q; Tanbo T; Gjersvik P
    Br J Dermatol; 2015 Nov; 173(5):1156-62. PubMed ID: 26189484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional CO
    Stewart K; Javaid S; Schallen KP; Bartlett S; Carlson NA
    Lasers Surg Med; 2022 Jan; 54(1):138-151. PubMed ID: 34541702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.